RO, A., AA, R., RM, E., MM, E., MZ, E., & LK, E. (2018). Praziquantel–lipid nanocapsules: An oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting. Dove Medical Press.
Chicago Style (17th ed.) CitationRO, Amara, Ramadan AA, El-Moslemany RM, Eissa MM, El-Azzouni MZ, and El-Khordagui LK. Praziquantel–lipid Nanocapsules: An Oral Nanotherapeutic with Potential Schistosoma Mansoni Tegumental Targeting. Dove Medical Press, 2018.
MLA (8th ed.) CitationRO, Amara, et al. Praziquantel–lipid Nanocapsules: An Oral Nanotherapeutic with Potential Schistosoma Mansoni Tegumental Targeting. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.